Myriad Genetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.03.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Myriad Genetics, Inc. (MYGN) (PR Newswire)
15.03.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myriad Genetics, Inc. - MYGN (PR Newswire)
15.03.18	Scott+Scott Attorneys at Law LLP Announces Investigation into Myriad Genetics, Inc. (MYGN) (PR Newswire)
07.02.18	GILD's Sales Wane, SGMO Safe With CHAMPIONS, All's Not Well With Veterinarians? (RTTNews)
06.02.18	Myriad Genetics Raises FY18 Financial Guidance - Quick Facts (RTTNews)
06.02.18	Myriad Genetics Inc. Q2 Income Advances (RTTNews)
03.01.18	Myriad, AstraZeneca Expand Collaboration To Include MyChoice HRD Plus Diagnostic (RTTNews)
12.12.17	Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib (RTTNews)
07.11.17	Myriad Genetics Inc. Q1 Income Climbs 14% (RTTNews)
03.11.17	DRNA Soars On NASH Deal, JUNO Transcends Expectations, FMI On Solid Footing (RTTNews)
19.10.17	Assurex: Study Shows GeneSight Statistically Improves Treatment Response In GAD (RTTNews)
02.10.17	Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month (PR Newswire)
07.09.17	Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month (PR Newswire)
08.08.17	Myriad Genetics Inc. Q4 Earnings Decline 21% (RTTNews)
04.05.17	Gainers & Losers Of May 3: PIRS, MYGN, XENT, RXDX, SPPI... (RTTNews)
03.05.17	Myriad Genetics Inc. Earnings Retreat 39% In Q3 (RTTNews)
02.05.17	Myriad Genetics Increases Annual Revenue Guidance, Narrows Adj. EPS Guidance (RTTNews)
27.04.17	Technical Roundup on Research Services Stocks -- Myriad Genetics, QIAGEN, INC Research, and Bioanalytical Systems (PR Newswire)
06.04.17	Myriad Genetics To Collaborate With BeiGene - Quick Facts (RTTNews)
21.03.17	Research Reports on Services Equities -- H&R Block, VCA Inc., Myriad, and QIAGEN (PR Newswire)
10.02.17	Myriad Genetics to Join S&P SmallCap 600 (PR Newswire)
08.02.17	MÄRKTE USA/Wenig Bewegung - Wall Street bleibt nahe am Rekordhoch (Dow Jones)
08.02.17	MÄRKTE USA/Wall Street mit leichten Abgaben - aber keiner Korrektur (Dow Jones)
08.02.17	MÄRKTE USA/Wall Street vor leichten Abgaben - aber keiner Korrektur (Dow Jones)
07.02.17	Myriad Genetics Inc. Profit Drops 48% In Q2 (RTTNews)
13.01.17	How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta (PR Newswire)
09.12.16	Myriad: EndoPredict Test Outperforms In Predicting Breast Cancer Recurrence Risk (RTTNews)
02.12.16	Research Reports Coverage on Services Stocks -- Myriad Genetics, Qiagen, INC Research, and La Quinta (PR Newswire)
01.11.16	Myriad Genetics Inc. Profit Retreats 46% In Q1 (RTTNews)
08.10.16	Myriad's myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib (GlobeNewswire)
09.08.16	Myriad Genetics Issues Q1, FY17 Guidance; Shares Plunge (RTTNews)
09.08.16	Myriad Genetics Inc. Q4 Profit Drops 10% (RTTNews)
11.07.16	Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute (GlobeNewswire)
29.06.16	Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer (RTTNews)
31.05.16	Myriad Acquires Sividon Diagnostics (GlobeNewswire)
03.05.16	Myriad Genetics Inc. Earnings Advance 2% In Q3 (RTTNews)
03.05.16	Myriad Genetics Updates FY16 Guidance; Q3 Profit Tops Estimates (RTTNews)
30.03.16	Myriad: MyRisk Test Identifies 70% More Deleterious Mutations Than BRCA Testing (RTTNews)
22.02.16	Myriad Expands Diagnostic Research Collaboration With Tesaro, Merck (RTTNews)
02.02.16	Myriad Genetics Raises FY16 Earnings Guidance - Quick Facts (RTTNews)
02.02.16	Myriad Genetics Inc. Reveals 12% Increase In Q2 Profit (RTTNews)
03.11.15	Myriad Genetics Inc. Q1 Profit Rises 54% (RTTNews)
08.10.15	Myriad To Highlight New Data On MyPath Melanoma At ASDP Meeting - Quick Facts (RTTNews)
01.10.15	Myriad Appoints Jan Schluchter as Chief Commercial Officer for Europe (GlobeNewswire)
24.09.15	Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting (GlobeNewswire)
11.08.15	Myriad Genetics Profit Misses Estimates, Outlook Weak; Stock Down 4% (RTTNews)
11.08.15	EARNINGS SUMMARY: Details of Myriad Genetics Inc. Q4 Earnings Report (RTTNews)
29.05.15	Myriad Significantly Advances The MyChoice HRD Companion Diagnostic Test (RTTNews)
05.05.15	Myriad Genetics Posts Lower Q3 Profit; Cuts FY15 Outlook Again (RTTNews)
01.04.15	Myriad, AstraZeneca Expand Research Collaboration On Lynparza - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12.12.24		Schwacher Handel: NASDAQ Composite am Donnerstagmittag schwächer
11.12.24		Gute Stimmung in New York: NASDAQ Composite zum Handelsende mit Gewinnen
10.12.24		Börse New York: NASDAQ Composite liegt am Mittag im Plus
06.12.24		NASDAQ Composite aktuell: NASDAQ Composite letztendlich im Plus
06.12.24		Freitagshandel in New York: NASDAQ Composite nachmittags in Grün
06.12.24		Freundlicher Handel in New York: NASDAQ Composite am Mittag stärker
06.12.24		Starker Wochentag in New York: NASDAQ Composite klettert zum Handelsstart
04.11.24		Börse New York in Rot: NASDAQ Composite gibt am Mittag nach

12.12.24

Schwacher Handel: NASDAQ Composite am Donnerstagmittag schwächer

11.12.24

Gute Stimmung in New York: NASDAQ Composite zum Handelsende mit Gewinnen

10.12.24

Börse New York: NASDAQ Composite liegt am Mittag im Plus

06.12.24

NASDAQ Composite aktuell: NASDAQ Composite letztendlich im Plus

06.12.24

Freitagshandel in New York: NASDAQ Composite nachmittags in Grün

06.12.24

Freundlicher Handel in New York: NASDAQ Composite am Mittag stärker

06.12.24

Starker Wochentag in New York: NASDAQ Composite klettert zum Handelsstart

04.11.24

Börse New York in Rot: NASDAQ Composite gibt am Mittag nach

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Myriad Genetics Inc.

Aktien Top/Flop

Myriad Genetics Peer Group Nachrichten

Meistgelesene Nachrichten